Index S&P 500
P/E 22.90
EPS (ttm) 7.78
Insider Own 0.20%
Shs Outstand 202.32M
Perf Week 2.12%
Market Cap 35.68B
Forward P/E 14.00
EPS next Y 12.73
Insider Trans -94.13%
Shs Float 162.29M
Perf Month 5.14%
Income 1.62B
PEG 2.83
EPS next Q 2.81
Inst Own 72.40%
Short Float / Ratio 3.19% / 4.22
Perf Quarter 19.13%
Sales 247.54B
P/S 0.14
EPS this Y 8.90%
Inst Trans 0.01%
Short Interest 5.18M
Perf Half Y 4.66%
Book/sh 1.39
P/B 128.22
EPS next Y 7.37%
ROA 2.80%
Target Price 188.50
Perf Year 21.72%
Cash/sh -
P/C -
EPS next 5Y 8.08%
ROE -
52W Range 135.14 - 176.68
Perf YTD 7.55%
Dividend 1.94
P/FCF 17.39
EPS past 5Y 37.40%
ROI 34.50%
52W High 0.87%
Beta 0.53
Dividend % 1.09%
Quick Ratio 0.50
Sales past 5Y 9.30%
Gross Margin 3.40%
52W Low 31.88%
ATR 3.07
Employees 39000
Current Ratio 0.90
Sales Q/Q 9.90%
Oper. Margin 0.90%
RSI (14) 67.88
Volatility 1.57% 1.81%
Optionable Yes
Debt/Eq 17.51
EPS Q/Q -17.50%
Profit Margin 0.70%
Rel Volume 0.65
Prev Close 176.45
Shortable Yes
LT Debt/Eq 16.57
Earnings May 02 BMO
Payout 24.00%
Avg Volume 1.23M
Price 178.22
Recom 2.00
SMA20 3.35%
SMA50 5.71%
SMA200 12.29%
Volume 793,787
Change 1.00%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-31-23 Initiated
Citigroup
Buy
$185
Jan-31-23 Resumed
Evercore ISI
Outperform
$185
Oct-11-22 Upgrade
BofA Securities
Neutral → Buy
$160 → $169
Aug-22-22 Resumed
Morgan Stanley
Equal-Weight
Jul-11-22 Downgrade
Evercore ISI
Outperform → In-line
$150
Jun-07-22 Upgrade
Deutsche Bank
Hold → Buy
$167 → $178
May-26-22 Upgrade
Barclays
Equal Weight → Overweight
Apr-12-22 Downgrade
Morgan Stanley
Overweight → Equal-Weight
$178
Apr-01-22 Resumed
Credit Suisse
Outperform
$180
Feb-04-21 Upgrade
Evercore ISI
In-line → Outperform
Jan-06-21 Upgrade
BofA Securities
Underperform → Neutral
Jun-15-20 Upgrade
Morgan Stanley
Equal-Weight → Overweight
$112
Apr-23-20 Resumed
Credit Suisse
Outperform
$105
Apr-01-20 Upgrade
JP Morgan
Neutral → Overweight
$93 → $106
Feb-07-20 Upgrade
Robert W. Baird
Neutral → Outperform
$112
Sep-12-19 Initiated
Deutsche Bank
Hold
Apr-11-19 Initiated
Guggenheim
Buy
Apr-10-19 Downgrade
Evercore ISI
Outperform → In-line
Apr-10-19 Downgrade
BofA/Merrill
Buy → Underperform
Jan-17-19 Initiated
UBS
Buy
$89
Show Previous Ratings
Jun-09-23 02:08PM (The Wall Street Journal)
08:18AM
Jun-08-23 11:30AM
Jun-01-23 11:31AM
May-29-23 10:43AM
04:45PM
Loading…
May-24-23 04:45PM (Investor's Business Daily)
06:50AM
May-17-23 09:40AM
08:07AM
May-16-23 02:35PM
02:32PM
11:39AM
May-15-23 01:10PM
12:36PM
May-12-23 11:48AM
10:58AM
Loading…
10:58AM
May-11-23 11:26PM
11:21PM
10:18PM
01:04PM
10:08AM
May-10-23 11:39AM
10:53AM
May-09-23 10:47AM
07:39AM
06:33AM
May-06-23 08:04AM
May-05-23 02:49PM
11:36AM
11:29AM
09:40AM
Loading…
09:40AM
08:17AM (American City Business Journals)
May-04-23 12:45PM
May-03-23 09:40AM
07:22AM
May-02-23 10:58PM (Thomson Reuters StreetEvents)
08:08PM
03:14PM
01:48PM
08:13AM
07:55AM
06:30AM
Apr-26-23 10:41AM
Apr-25-23 10:19AM
Apr-24-23 03:46PM (Investor's Business Daily)
03:26PM
Apr-21-23 11:28AM
Apr-20-23 03:17PM
08:59AM
08:30AM
07:22AM
Apr-19-23 11:12AM
Apr-12-23 04:36AM
Mar-31-23 06:38AM
Mar-29-23 07:50PM
04:30PM
Mar-27-23 05:45PM
Mar-23-23 12:57PM
Mar-22-23 06:15PM
Mar-21-23 09:40AM
Mar-16-23 11:16PM
Mar-15-23 10:54AM
Mar-09-23 06:15PM
Mar-03-23 10:31AM
05:13AM
Mar-02-23 10:19AM
Mar-01-23 05:18AM
Feb-28-23 11:27AM
Feb-27-23 12:45PM
09:40AM
Feb-24-23 08:42AM
Feb-23-23 01:34PM
01:19PM
10:23AM
09:45AM
Feb-22-23 06:13AM
Feb-21-23 09:05AM
Feb-17-23 07:58AM
Feb-07-23 09:40AM
Feb-06-23 06:05AM
Feb-04-23 07:10AM
Feb-03-23 11:23AM (American City Business Journals)
09:40AM
08:24AM
Feb-02-23 04:00PM
08:03AM
Feb-01-23 02:04PM (American City Business Journals)
12:57PM
11:16AM
07:45AM
06:59AM
06:30AM
Jan-27-23 08:44AM
Jan-26-23 10:01AM
Jan-25-23 10:59AM
10:00AM
Jan-24-23 09:43AM (American City Business Journals)
09:14AM
07:00AM
05:00AM (The Wall Street Journal)
AmerisourceBergen Corporation sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The company also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; and pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to customers in the companion animal and production animal markets, as well as demand-creating sales force services to manufacturer. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. The company's International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; and distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers and hospitals primarily in Europe. This segments also provides specialty transportation and logistics services for the biopharmaceutical industry. The company was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Cleary James F Chief Financial Officer May 18 Option Exercise 75.61 38,376 2,901,609 107,496 May 19 04:04 PM Campbell Elizabeth S Executive Vice President May 17 Option Exercise 77.53 3,305 256,237 19,393 May 19 04:02 PM Campbell Elizabeth S Executive Vice President May 17 Sale 174.12 7,500 1,305,884 11,893 May 19 04:02 PM Walgreens Boots Alliance, Inc. 10% Owner May 11 Sale 170.77 292,792 50,000,090 33,366,388 May 15 05:18 PM COLLIS STEVEN H Chairman, President & CEO May 09 Option Exercise 77.53 10,499 813,987 268,466 May 10 04:03 PM COLLIS STEVEN H Chairman, President & CEO May 09 Sale 169.52 10,499 1,779,790 257,967 May 10 04:03 PM COLLIS STEVEN H Chairman, President & CEO Apr 11 Option Exercise 77.53 10,499 813,987 268,466 Apr 13 04:10 PM COLLIS STEVEN H Chairman, President & CEO Apr 11 Sale 167.34 10,499 1,756,903 257,967 Apr 13 04:10 PM COLLIS STEVEN H Chairman, President & CEO Mar 14 Option Exercise 77.53 10,499 813,987 268,466 Mar 15 04:05 PM COLLIS STEVEN H Chairman, President & CEO Mar 14 Sale 150.00 10,499 1,574,850 257,967 Mar 15 04:05 PM Clark Gina Executive Vice President Mar 01 Sale 156.22 1,924 300,565 26,733 Mar 03 04:08 PM COLLIS STEVEN H Chairman, President & CEO Feb 14 Option Exercise 77.53 10,499 813,987 268,466 Feb 16 04:06 PM COLLIS STEVEN H Chairman, President & CEO Feb 14 Sale 159.28 10,499 1,672,281 257,967 Feb 16 04:06 PM Krikorian Lazarus SVP & Chief Accounting Officer Feb 07 Sale 155.82 5,711 889,888 18,732 Feb 09 04:06 PM COLLIS STEVEN H Chairman, President & CEO Jan 17 Option Exercise 77.53 10,499 813,987 268,466 Jan 19 04:06 PM COLLIS STEVEN H Chairman, President & CEO Jan 17 Sale 164.28 10,499 1,724,776 257,967 Jan 19 04:06 PM Donato Leslie E EVP & Chief Strategy Officer Dec 22 Sale 170.00 930 158,100 6,054 Dec 23 04:04 PM Krikorian Lazarus SVP & Chief Accounting Officer Dec 21 Option Exercise 89.58 2,218 198,688 22,225 Dec 22 04:04 PM Krikorian Lazarus SVP & Chief Accounting Officer Dec 21 Sale 169.24 2,218 375,374 20,007 Dec 22 04:04 PM Battaglia Silvana Executive Vice President Dec 16 Option Exercise 86.09 9,031 777,479 19,815 Dec 20 04:02 PM Battaglia Silvana Executive Vice President Dec 16 Sale 167.00 9,852 1,645,284 10,784 Dec 20 04:02 PM COLLIS STEVEN H Chairman, President & CEO Dec 13 Option Exercise 75.61 45,920 3,472,011 303,887 Dec 14 04:52 PM COLLIS STEVEN H Chairman, President & CEO Dec 13 Sale 165.62 45,920 7,605,365 257,967 Dec 14 04:52 PM COLLIS STEVEN H Chairman, President & CEO Dec 12 Sale 166.01 33,000 5,478,330 257,967 Dec 14 04:52 PM Clark Gina Executive Vice President Dec 12 Sale 166.30 392 65,190 28,657 Dec 14 05:33 PM Donato Leslie E EVP & Chief Strategy Officer Dec 09 Sale 166.12 3,014 500,686 6,984 Dec 12 04:20 PM Walgreens Boots Alliance, Inc. 10% Owner Dec 08 Sale 165.08 5,961,534 984,130,033 33,659,180 Dec 12 05:26 PM Walgreens Boots Alliance, Inc. 10% Owner Nov 07 Sale 154.60 13,234,153 2,046,000,054 39,629,714 Nov 09 08:00 AM Mauch Robert P. Executive Vice President & COO Nov 04 Sale 160.00 21,802 3,488,320 20,197 Nov 04 06:19 PM COLLIS STEVEN H Chairman, President & CEO Oct 11 Option Exercise 75.61 11,480 868,003 216,658 Oct 12 04:31 PM COLLIS STEVEN H Chairman, President & CEO Oct 11 Sale 141.72 11,480 1,626,946 205,178 Oct 12 04:31 PM COLLIS STEVEN H Chairman, President & CEO Sep 13 Option Exercise 75.61 11,480 868,003 216,658 Sep 15 04:24 PM COLLIS STEVEN H Chairman, President & CEO Sep 13 Sale 142.40 11,480 1,634,752 205,178 Sep 15 04:24 PM Donato Leslie E EVP & Chief Strategy Officer Sep 02 Option Exercise 0.00 2,975 0 4,784 Sep 06 04:48 PM Clark Gina Executive Vice President Aug 30 Sale 146.80 288 42,278 15,526 Sep 01 04:05 PM COLLIS STEVEN H Chairman, President & CEO Aug 09 Option Exercise 75.61 11,480 868,003 216,658 Aug 11 04:14 PM COLLIS STEVEN H Chairman, President & CEO Aug 09 Sale 144.25 11,480 1,655,990 205,178 Aug 11 04:14 PM COLLIS STEVEN H Chairman, President & CEO Jul 12 Option Exercise 75.61 11,480 868,003 216,658 Jul 14 04:04 PM COLLIS STEVEN H Chairman, President & CEO Jul 12 Sale 142.35 11,480 1,634,178 205,178 Jul 14 04:04 PM Donato Leslie E EVP & Chief Strategy Officer Jul 01 Option Exercise 0.00 1,431 0 2,342 Jul 22 04:05 PM COLLIS STEVEN H Chairman, President & CEO Jun 14 Option Exercise 75.61 11,480 868,003 216,658 Jun 16 04:20 PM COLLIS STEVEN H Chairman, President & CEO Jun 14 Sale 141.22 11,480 1,621,206 205,178 Jun 16 04:20 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite